Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women

European Heart Journal

Volumn 21, Issue 3, 2000, Pages 190-197

  Fak, A S ^a   Erenus, M ^a   Tezcan, H ^a   Caymaz, O ^a   Atagunduz P ^a   Oktay, S ^a   Oktay, A ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hormone replacement therapy; Hypercholesterolaemia; Oestrogen; Progesterone; Simvastatin

Indexed keywords

CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG POTENTIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SIMVASTATIN; TIME FACTORS;

EID: 0034096389     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1582     Document Type: Article

References (31)

1. Stamfer MJ, Colditz GA, Willet WC. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses' Health Study. N Engl J Med. 325:1991;756-762.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence. Prev Med. 20:1991;47-63.
3. Nabulshi AA, Folsom AR, White A. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 328:1993;1069-1075.
4. Rijpkema AHM, van der Sanden AA, Rujis AHC. Effects of postmenopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins. Maturitas. 12:1990;259-285.
5. Lobo RA. Clinical review: effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab. 73:1991;925-930.
6. Sempos CT, Cleeman JL, Carroll MD. Prevalence of high blood cholesterol among US adults an update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 269:1993;3009-3014.
7. JAMA. 269:1993;3015-3023.
8. Lancet. 344:1994;1383-1389.
9. Bradfort RH, Downton M, Chremos AN. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia. Ann Intern Med. 118:1993;850-855.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
11. Ann Intern Med. 117:1992;1038-1041.
12. Castelli WP, Garison RJ, Wilson PW, Abbot RD, Kalovsdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Heart Study. JAMA. 256:1986;2835-2838.
13. JAMA. 251:1984;351-364.
14. Akahoshi M, Soda M, Nakashima E, Shimaoka K, Seto S, Yano K. Effects of menopause on trends of serum cholesterol, blood pressure and body mass index. Circulation. 94:1996;61-66.
15. Barret-Connor, E, Bush, TL, Estrogen and coronary heart disease in women, JAMA, 1991, 265, 1861, 7.
16. Grodstein F, Stampfer MJ, Colditz G. Postmenopausal hormone replacement therapy and mortality. N Engl J Med. 336:1997;1769-1775.
17. Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol. 26:1995;1403-1410.
18. JAMA. 273:1995;199-208.
19. Davidson M, Testolin LM, Maki KC, von Duvillard S, Drennan K. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women. Arch Intern Med. 157:1997;1186-1192.
20. Darling GM, Johns JA, McCloud PI, Davis SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med. 337:1997;595-601.
21. Denke MA. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women. Am J Med. 99:1995;29-35.
22. Walsh BW, Schiff I, Rosner B. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 325:1991;1196-1204.
23. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 33:1992;1569-1582.
24. Illingworth DR, Stein EA, Knopp RH. A randomized multicenter trial comparing the efficacy of simvastatin and fluvastatin. J Cardiovasc Pharmacol Therapeut. I:1996;23-30.
25. Cardiology. 85:1994;244-254.
26. Sbarouni E, Kyriakides ZS, Kremastinos DT. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. J Am Coll Cardiol. 32:1998;1244-1250.
27. Larsen ML, Illingworth DR. Drug treatment in dyslipoproteinemia. Med Clin North Am. 78:1994;225-246.
28. Bersot TP, Mahley RW. A preliminary report on the sensitivity of plasma lipoproteins to low-dose simvastatin in nine Turkish men. Arch Turkish Soc Cardiol. 26:1998;40-46.
29. Tikkanen MJ, Nikkilä EA, Kuusi T, Sipinen SU. Post-menopausal hormone replacement therapy: effects on serum lipids and lipoproteins: a review. Maturitas. 8:1986;7-17.
30. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women. Arch Intern Med. 153:1993;2209-2216.
31. Hogan T. Health and economic issues in the prevention of coronary artery disease. Am J Cardiol. 76:1995;140A-142A.